Stryker Corporation (NYSE:SYK) insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $163.76, for a total transaction of $818,800.00. Following the completion of the transaction, the insider now directly owns 94,253 shares of the company’s stock, valued at approximately $15,434,871.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Stryker Corporation (SYK) opened at $153.67 on Thursday. The company has a current ratio of 2.29, a quick ratio of 1.59 and a debt-to-equity ratio of 0.66. Stryker Corporation has a 1-year low of $122.01 and a 1-year high of $170.00. The firm has a market cap of $57,782.29, a P/E ratio of 57.34, a price-to-earnings-growth ratio of 2.22 and a beta of 0.70.
Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.01. Stryker had a net margin of 8.20% and a return on equity of 24.55%. The company had revenue of $3.47 billion for the quarter, compared to analysts’ expectations of $3.42 billion. During the same quarter last year, the company earned $1.78 earnings per share. The firm’s revenue for the quarter was up 9.9% on a year-over-year basis. sell-side analysts expect that Stryker Corporation will post 7.12 EPS for the current year.
Several research analysts have recently commented on the stock. Needham & Company LLC reissued a “hold” rating on shares of Stryker in a research note on Wednesday, January 31st. Leerink Swann lifted their price target on shares of Stryker from $177.00 to $184.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Piper Jaffray Companies reiterated a “buy” rating and issued a $170.00 price target on shares of Stryker in a research note on Wednesday, January 31st. Citigroup reiterated a “market perform” rating and issued a $165.00 price target (up previously from $156.00) on shares of Stryker in a research note on Thursday, February 1st. They noted that the move was a valuation call. Finally, Robert W. Baird upgraded shares of Stryker from a “neutral” rating to an “outperform” rating in a research note on Friday, November 24th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $162.50.
Several institutional investors have recently made changes to their positions in SYK. Koch Industries Inc. increased its holdings in shares of Stryker by 34,120.3% in the 2nd quarter. Koch Industries Inc. now owns 1,260,675 shares of the medical technology company’s stock valued at $1,252,000 after acquiring an additional 1,256,991 shares during the period. BlackRock Inc. increased its holdings in shares of Stryker by 5.2% in the 2nd quarter. BlackRock Inc. now owns 23,115,853 shares of the medical technology company’s stock valued at $3,208,017,000 after acquiring an additional 1,139,082 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Stryker by 2,237.8% in the 2nd quarter. Janus Henderson Group PLC now owns 1,019,254 shares of the medical technology company’s stock valued at $141,452,000 after acquiring an additional 975,656 shares during the period. Vanguard Group Inc. increased its holdings in shares of Stryker by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 24,078,709 shares of the medical technology company’s stock valued at $3,341,643,000 after acquiring an additional 657,656 shares during the period. Finally, APG Asset Management N.V. increased its holdings in shares of Stryker by 117.1% in the 3rd quarter. APG Asset Management N.V. now owns 583,736 shares of the medical technology company’s stock valued at $82,902,000 after acquiring an additional 314,800 shares during the period. 74.85% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://sportsperspectives.com/2018/02/08/stryker-corporation-syk-insider-lonny-j-carpenter-sells-5000-shares.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.